A Danish clinical trial found that semaglutide, a GLP-1 weight loss drug, reduced heavy drinking days and overall alcohol intake in obese patients with alcohol use disorder. Over 26 weeks, ...

Doctronic reports new AI analysis reveals GLP-1 medications may cause underreported symptoms like menstrual irregularities ...

Weekly injection semaglutide - sold under brand names Wegovy and Ozempic - helped addicts cut number of heavy drinking days ...

Canada has approved its first generic semaglutide injection, potentially lowering costs and easing shortages of the blockbuster diabetes and weight-loss drug. The move comes as new studies raise ...

Like antibiotics, the weight-loss drugs risk misuse. Read more at straitstimes.com. Read more at straitstimes.com.

The lead study author and doctors share how these unknown side effects can impact your training and the best ways to adjust ...

We worked with testers, whose identities we have verified, to test the products and services mentioned in this story. Due to ...

As many of us know, keeping weight in check can be hard. National numbers certainly reflect this. Rates of overweight and ...

Ivim Health reports on the effectiveness of GLP-1 pills vs. Ozempic, emphasizing personalized care for obesity management.

Orforglipron is a new oral GLP-1 drug that outperforms oral semaglutide in blood sugar control and weight loss while offering ...

Phase 3 trial data show a synthetic semaglutide injection provides glycemic control comparable to Ozempic in patients with type 2 diabetes.

Yale Medicine specialists explain how new oral forms of GLP-1 obesity medications work, how effective they are, and what to ...